|
Reference | Tissue | Subject | Comparative | Training | Results |
|
[58] | Muscle | Humans | Sedentary and active youths and elderly | Single bout of treadmill running of 45 min at 70–75% VO2max plus exercise until exhaustion at 90% VO2max | ↓ (mRNA): Fis1; Mfn1 |
NS: PGC-1α; TFAM |
[31] | Muscle | Humans | Sedentary elderly and active elderly Sedentary elderly + training | 16 weeks of aerobic exercise (bike, walk, run, or row), 3 times/week at 75–80% HR | ↑ (mRNA): PGC-1α, TFAM (sedentary elderly + training) |
NS (mRNA): PGC-1α, TFAM (sedentary elderly versus active elderly) |
[81] | Muscle | Humans | Trained elderly and untrained elderly Untrained elderly + acute exercise | Single bout of high intensity interval exercise on a bicycle ergometer for 20 min at 80% of peak power output | ↑ (mRNA): PGC-1α (untrained + acute exercise) |
↑: PGC-1α (trained versus untrained elderly) |
NS: PGC-1α (untrained + acute exercise) |
[87] | Muscle | Humans | Sedentary elderly Active elderly | Without exercise intervention | ↑ (mRNA): Bnip3; Drp1; Parkin; beclin1 |
NS (mRNA): Mfn2; PINK1; LC3 |
NS: beclin1 |
[45] | Carotid arteries | Mouse | Sedentary and active youths and elderly | 10 weeks of voluntary aerobic exercise in a wheel running | NS: PGC-1α; Fis1; Mfn2 |
[83] | Brain | Mouse | Elderly | 3 weeks of treadmill running for 60 min at 15–19 m/min and 10° incline | NS (cortex): PGC-1α, TFAM, Mfn2; LC3II |
NS (striatum): PGC-1α, TFAM, Drp1, Mfn2; LC3II |
↑ (cortex): Drp1 |
[82] | Muscle | Humans | Elderly | Single bout of bicycle exercise at 75% VO2max until exhaustion | ↑ (mRNA): PGC-1α |
NS (mRNA): TFAM |
[46] | Muscle | Humans | Youths/elderly | Without exercise intervention | NS: PGC-1α; TFAM; Mfn2; OPA1; Drp1; Fis1 |
[47] | Muscle | Rats | Youths/elderly | 12 weeks of treadmill running 5 times/week for 45 min at 17.5 m/min and 10° incline | ↑: PGC-1α; TFAM |
NS (mRNA): PGC-1α; TFAM |
[48] | Muscle | Rats | Youths/elderly | 6 weeks of treadmill running for 60 min at 10–22 m/min and 5–10% incline | ↑: PGC-1α |
↓: Mfn1 |
NS: TFAM; Fis1 |
[30] | Muscle | Humans | Youths/elderly | 12 weeks of cycling 3-4 times/week at 60–80% HR reserve for 20–45 min | ↑: PGC-1α; OPA1; Mfn1; Mfn2; Fis1 |
[49] | Muscle | Humans | Youths/elderly | Without exercise intervention | ↑: PGC-1α; TFAM |
[80] | Muscle | Rats | Youths/elderly | 7 days of electroestimulation 3 h/day at 10 Hz for 0.1 ms duration | ↑: PGC-1α; TFAM |
[68] | Muscle | Humans | Youths/elderly | Single bout of resistance training (4 sets of rept. at 75% 1RM with 2 min rest between sets) | ↑ (mRNA): PGC-1α (3 h); TFAM (24 h); LC3II (3 h) |
↑: LC3II (48 h) |
NS (mRNA): Nix; Bnip3 |
NS: Parkin; PINK1; VDAC1; beclin1 |
[79] | Muscle | Mouse | Youths/elderly | 6 weeks of voluntary aerobic exercise in wheels running | ↑: PGC-1α |
[84] | Muscle | Mouse | Elderly | Single bout of voluntary aerobic exercise in wheels running for 3 h | NS: OPA1; Mfn2 |
[72] | Muscle | Humans | Youths and active and sedentary elderly | Without exercise intervention | ↓: Bnip3 |
NS: PGC-1α; beclin1 |
[85] | Muscle | Humans | Elderly | 12 weeks of aerobic exercise for 60 min (20 min cycle ergometer and 40 min treadmill walking) at 80–85% HRmax 5 days/week | ↑ (mRNA): OPA1; Drp1 |
↓: phosphorylated Drp1 |
NS (mRNA): Mfn1; Mfn2; Fis1; PINK1; Parkin |
[71] | Muscle | Humans | Youths/elderly | 14 days of immobilization and 20 sessions of aerobic cycle ergometer training with 48–58 min at 85% HRmax | ↑ (immobilization + training versus immobilization): VDAC1 |
NS (immobilization + training versus control): VDAC1 |
[89] | Muscle | Humans | Elderly | 24 weeks of combined exercise (walking + strength training + flexibility) 2-3 times/week at moderate intensity | NS (mRNA): Bnip3 |
↑ (mRNA): PGC-1α; TFAM; LC3II |
↑: TFAM |
[75] | Muscle | Humans | Youths/elderly | 5 days of bed rest and 8 weeks of high intensity resistance exercise | ↑: LC3II/I |
NS: beclin1 |
[10] | PBMCs | Humans | Elderly | 8 weeks of aerobic training | ↑: LC3II/I¸beclin1 |
[2] | PBMCs | Humans | Elderly | 8 weeks of resistance training | ↑: beclin1 |
NS: LC3II/I |
|